Table 1.

Type of anticoagulation used in studies included in the meta-analysis.^16–41

Study name	Use of anticoagulation
Bompard et al.	Enoxaparin 40 mg once daily in medical floor Enoxaparin 40 mg every 12 h in ICU Enoxaparin 40 mg every 12 h in obese patients irrespective of floor or ICU
Al-Samkari et al.	Enoxaparin 40 mg SC daily OR Unfractionated heparin 5000 U SC every 8–12 h in medical floor Enoxaparin 40 mg SC daily OR Unfractionated heparin 5000 U SC every 8–12 h in ICU Enoxaparin 40 mg SC every 12 h OR Unfractionated heparin 5000- 7500 U SC every 8 h in obese patients
Chen et al.	Low-molecular-weight heparin
Faggiano et al.	Unfractionated or low-molecular-weight heparin
Fauvel et al.	Daily low-molecular-weight heparin or twice daily subcutaneous unfractionated heparin; intermediate dose (double the preventive dose); and therapeutic dose
Koleilat et al.	Low-molecular-weight heparin prophylaxis dose, subcutaneous heparin prophylaxis, therapeutic anticoagulation (unfractionated heparin, direct oral anticoagulant), therapeutic bivalirudin, prophylactic apixaban
Larsen et al.	Low-molecular-weight heparin prophylaxis
Léonard-Lorant et al.	Low-molecular-weight heparin therapeutic dose
Manjunath et al.	Prophylaxis using subcutaneous, unfractionated heparin (5000 U two times a day), low-molecular-weight heparin (40 mg daily), or home regimen of novel oral anticoagulants (two patients with atrial fibrillation)
Gómez et al.	Unfractionated heparin or low-molecular-weight heparin for prophylaxis dose
Kaminetzky et al.	Prophylactic anticoagulation: subcutaneous enoxaparin (40–60 mg according to body mass index) or subcutaneous heparin Therapeutic anticoagulation: subcutaneous enoxaparin (1 mg/kg) twice daily or intravenous heparin
Middeldorp et al.	Low-molecular-weight heparin prophylaxis dose
Ren et al.	30 to 40 mg low-molecular-weight heparin (subcutaneous injection) once daily
Santoliquido et al.	Prophylactic dose of anticoagulant (either enoxaparin 40 mg once daily or fondaparinux 2.5 mg daily)
Stoneham et al.	Therapeutic anticoagulation with low-molecular-weight heparin
Whyte et al.	Therapy with enoxaparin, rivaroxaban, apixaban, edoxaban, and unfractionated heparin infusion
Zhang et al.	Therapy with low-molecular-weight heparin

ICU, intensive care unit.